Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) Return on Equity (2019 - 2025)

Historic Return on Equity for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to 0.52%.

  • Nexgel's Return on Equity rose 2800.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.62% for FY2024, which is 1200.0% down from last year.
  • According to the latest figures from Q3 2025, Nexgel's Return on Equity is 0.52%, which was up 2800.0% from 0.55% recorded in Q2 2025.
  • Over the past 5 years, Nexgel's Return on Equity peaked at 0.31% during Q3 2023, and registered a low of 8.89% during Q3 2021.
  • Its 5-year average for Return on Equity is 1.39%, with a median of 0.56% in 2023.
  • Over the last 5 years, Nexgel's Return on Equity had its largest YoY gain of 95900bps in 2021, and its largest YoY loss of -42400bps in 2021.
  • Nexgel's Return on Equity (Quarter) stood at 0.57% in 2021, then increased by 9bps to 0.52% in 2022, then fell by -8bps to 0.56% in 2023, then decreased by -12bps to 0.63% in 2024, then grew by 16bps to 0.52% in 2025.
  • Its Return on Equity was 0.52% in Q3 2025, compared to 0.55% in Q2 2025 and 0.56% in Q1 2025.